ArticleVeterinary medicine and science2026
Safety Assessment of Mefepronic Acid in Sheep.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMefepronic acid is used as a choleretic agent in different animal species. Although mefepronic acid is used extra-label in sheep, information on its safety in this species is limited. The aim of this study was to determine the effects of mefepronic acid on serum oxidative stress, lipid metabolism and organ function parameters in sheep.
methodsMefepronic acid was administered to 10 sheep at a dose of 10 mg/kg (intramuscular, once daily, 3 days). Blood samples were taken at 0 and at 24, 48 and 72 h. 8-OHdG, MDA, SOD, GPX, CAT, CK-MB isoenzyme, troponin I, serum ALP, AST, ALT, total bilirubin, BUN, creatinine, cholesterol, triglycerides, LDL and HDL levels were measured.
resultsMefepronic acid administration resulted in a transient increase in 8-OHdG levels (p < 0.05) and a decrease in CAT levels (p < 0.05), a transient increase in CK-MB isoenzyme levels (p < 0.05), and a decrease in BUN, HDL and LDL levels (p < 0.05), but no effect on other parameters (p > 0.05).
conclusionAdministration of mefepronic acid to sheep may cause transient changes in oxidative stress parameters and CK-MB isoenzyme levels. However, these changes were not associated with an increase in troponin I levels or clinically significant myocardial damage. Mefepronic acid did not cause clinically significant adverse effects on liver or kidney function parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.